The only parameter in which our IHC analysis of CA IX expression in BC does not fully correspond with in silico analysis data (Figure 6) and earlier observations [27,28] is the significant association of CA IX positivity with HER2+ receptor status. The gene discussed is ERBB2; the disease is breast cancer.